Listed by the USPTO as ARNOLD, ERNST V
Tech Center 1600 • Art Units: 1600 1613 1614 1616 1617 1626
This examiner grants 48% of resolved cases
ARNOLD, ERNST V is assigned to tech center 1600 and art unit 1600. The examiner has 1395 resolved cases, a 48.2% allowance rate, and a median of 1164 days to allowance. The extensive record makes the profile useful for portfolio analysis, while the allowance rate indicates that applicants should expect prosecution outcomes to depend substantially on claim presentation and response quality.
The interview lift is 12.8%, indicating a positive but limited association in the available data. The companies listed are Applied Materials Inc., L'Oréal, and Cydex Pharmaceuticals Inc. The listed firms are GREENBERG TRAURIG, LLP (BOS), FOLEY & LARDNER LLP, and SUGHRUE MION, PLLC. Practitioners may want to pair interviews with disciplined written amendments and account for the median timing in filing and commercial planning.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18884577 | LIPID COMPOSITION | Final Rejection | FUJIFILM Corporation |
| 18205399 | Hemostatic Foam | Final Rejection | STRYKER EUROPEAN OPERATIONS HOLDINGS LLC |
| 17831796 | Oral Care Products and Methods | Final Rejection | BASF SE |
| 19016307 | PHARMACEUTICAL COMPOSITIONS FOR IMPROVING INTESTINAL BACTERIAL FLORA AND RELATED TREATMENT METHODS | Final Rejection | Murata Manufacturing Co., Ltd. |
| 18716339 | CONJUGATE COMPOUND AND METHOD FOR PRODUCING CONJUGATE COMPOUND | Non-Final OA | NIPPON SHOKUBAI CO., LTD. |
| 18674730 | PREPARATION OF PHARMACEUTICAL COMPOSITIONS USING SUPERCYCLE VAPOR PHASE DEPOSITION OF METAL OXIDES | Non-Final OA | Applied Materials, Inc. |
| 18839767 | SPONGES BASED ON COLLAGEN-LIKE PROTEINS | Final Rejection | Evonik Operations GmbH |
| 18842107 | OIL-IN-WATER EMULSION COMPOSITION | Non-Final OA | OTSUKA PHARMACEUTICAL FACTORY, INC. |
| 18717321 | COMPOSITION COMPRISING TWO PARTICULAR OXIDATION DYE PRECURSORS AND A PHOSPHORIC SURFACTANT | Non-Final OA | L'OREAL |
| 18679749 | HYBRID NAIL COMPOSITION | Final Rejection | L'ORÉAL |
| 18869120 | COSMETIC MATERIAL COMPOSITION AND FIBER TREATMENT COMPOSITION FOR HEAD DECORATION PRODUCTS | Non-Final OA | KAO CORPORATION |
| 18993843 | ANTIVIRUS COMPOSITE RESIN COMPOSITION WITH EXCELLENT VIRUS INACTIVATION FUNCTION AND COMPOSITE-RESIN-COATED STEEL SHEET USING SAME | Non-Final OA | POSCO CO., LTD |
| 18773063 | CO-FORMULATION AND CO-DELIVERY OF IONIZABLE COLLOID FORMING DRUGS WITH NUCLEIC ACIDS | Non-Final OA | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO |
| 18789155 | Method of using binary coating agents in powder coating to achieve enhanced properties of the coated powder and its blends having cohesive powders | Non-Final OA | New Jersey Institute of Technology |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy48.2% of resolved applications examined by Ernst V Arnold were allowed (1,395 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +12.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Ernst V Arnold took 1,164 days on average from filing to allowance.
Ernst V Arnold examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
